GMV Chart, page-1852

Hi Shori,

Yes you are correct that the CFDA is only for China.

GMV needs the CFDA for the Prizma and the CE for the chinese factory. It is GMV's intention to build the majority of the devices (Prizma and Patch) from the Chinese Factory as it is more economical price wise.

The revenue will start coming in for the Prizma and Patch from the following avenue's:
a. over the counter sales world wide,
b. prescription from GP's
c. government through hospitals and insurance companies
d. Aged care homes
e. Upon discharge from hospitals
f. IDTF
g. etc, etc, etc.

Their will be multi revenue streams coming in from both devices with recurring revenue coming in for the Patch. The Patch is the cash cow. The Prizma and Patch will revolutionize the private and public health care services as it will reduce staff required and increase productivity throughout Hospitals.

If you can imagine 10% of all hospitals in the world adopting GMV's products, well that is why this product is worth its weight in gold and the SP will indeed reflect that in given time.

Lets all stay focused and show patience for the CFDA.

Cheers Rubes